China is the world's largest API production base, and the export volume of veterinary APIs and pharmaceutical intermediates has been ranked first in the world for many years.
China is not only the world's largest producer and consumer of chemical products, but has also become the world's largest API production base since 2010. This status is due to China's ability to effectively meet domestic demand and sell a large number of products to the international market. China's veterinary APIs and pharmaceutical intermediates industry has high requirements for technical level, and the development of new products requires a lot of financial and human resources, with the characteristics of high investment, high risk, high return and long cycle. These efforts have enabled China's veterinary APIs and pharmaceutical intermediates to begin to occupy an extremely important position in the global pharmaceutical industry chain, exported to nearly 200 countries and regions around the world, and the export volume has been ranked first in the world for many years.
In addition, China's veterinary API manufacturers have also made remarkable achievements in technological innovation and product quality. For example, the veterinary API "Tyvalocin Tartrate" produced by Hubei Huisheng Biotechnology Co., Ltd. won the China Invention Patent Excellence Award, becoming the third company in the world to obtain a production license, and its products are exported to many countries and regions. These achievements reflect China's international competitiveness in the field of veterinary APIs and its influence in the global market.
